Level2 solution aims to help people living with type 2 diabetes improve their health

For people living with diabetes, the disease may impact many facets of their lives. This can include managing what they eat, finding time to stay active and tracking glucose levels — whether at home or work.

More than 38 million Americans¹ have diabetes (about 1 in 10), and about 90% to 95% of them have type 2 diabetes,² a form of the disease that may be influenced by lifestyle factors like physical inactivity and obesity.

Diabetes can be a costly challenge, especially for employers looking to best support their employees living with the disease. One-in-four health care dollars in the United States is spent on diabetes care.

According to the American Diabetes Association (ADA), diabetes amounts to a national epidemic that costs roughly $413 billion annually³ — including more than $106 billion in lost productivity.

Additionally, diabetes is associated with increased risk of costly health conditions and complications like heart disease, amputations, dementia and vision loss, according to the ADA.⁴ In fact, diabetes is the leading cause of new blindness in working age adults.

The right solution may help employees improve the most common form of the disease, type 2 diabetes, and even work towards remission, while helping reduce the total cost of care.

Level2® Specialty Care combines wearable technology with customized clinical support and aims to help improve the health of people living with type 2 diabetes.

For eligible employees, Level2 Specialty Care provides personalized steps with the potential to lower their glucose levels – including dietary suggestions and simplified activities that can help reduce blood sugars to a sustainable, healthy range.

Grounded in metabolic and behavioral science, Level2 equips eligible participants with continuous glucose monitors (CGM) and personalized support from a care team of doctors, nurses, coaches and registered dietitians to help encourage healthier lifestyle decisions, like food choices, exercise and sleep patterns.

A new analysis⁵ of those in Level2 Specialty Care recently presented at the American Diabetes Association annual conference found that 82% of Level2 participants logged goals and actions to support self-management on the Level2 app — a key indicator that members are actively engaging with the program.

The new study builds on a growing body of evidence⁶ about how programs like Level2 can help members living with type 2 diabetes improve their health and wellbeing.

Previous studies have shown that 73% of Level2 participants with a starting A1C level above 7.0 had clinically meaningful improvement in their blood glucose level with an average reduction in A1C of 1.4 percentage points after one year.

Among Level2 participants with at least 60 days of engaged participation, 63% experienced stable or improved A1C levels.

Level2 aims to center the care experience around eligible members with type 2 diabetes, while offering employers a tool that can help bend the cost curve of treating these employees.

Through the Level2 Assured Value Program, eligible employers with more than 100 covered employees living with type 2 diabetes will have 100% of program fees reconciled against clinical outcomes and actual medical and pharmacy claims savings. If actual value generated is less than paid program fees, Level2 gives back the difference to eligible employers.

“The leading technology and specialized clinical support that Level2 offers is truly a win-win for both the health of our employees with type 2 diabetes and the potential long-term cost savings of our organization,” said Loren Kennedy, senior vice president, World Travel Holdings.

While GLP-1 drugs are currently a trending topic among diabetes solutions, pairing FDA approved GLP-1 drugs with a solution like Level2 may be a win-win strategy for employers and employees. Self-insured employers may see more optimized value from the combination of these medications when used in tandem with a solution like the Level2 program.

“Level2 is one way we are working to reduce the impact of type 2 diabetes by helping people work to improve their condition while offering employers incentives to adopt evidence-based solutions,” said Dr. Rhonda L. Randall, chief medical officer for UnitedHealthcare’s commercial business.

Active members give Level2 a Net Promoter Score®* – a key measure of consumer satisfaction – of 82, significantly higher than industry benchmarks.

To learn more, visit mylevel2.com.